Understanding your competitive landscape is crucial to long-term success. However, it is a colossal task, with a multitude of data points, developments, and decisions for you and your team to track. And it is always evolving.
Our tools put all the insights you need within reach, helping you get to grips with risk, identify unmet needs, and better understand your growth drivers and product differentiators. Cut through the layers of complexity. Analyse the competition through a lens that’s specific to your therapeutic area or drug class. Discover opportunities, understand risk, plan the best points of entry for your investment, and stay competitive in the face of market changes.
Quickly generate a competitive landscape for both R&D and marketed products, for a more complete view of expected approval dates, current R&D costs, risk profiles, and product valuations (NPV). Gain insights on market trends such as shifts in patient preferences or demand.
Deepen your knowledge of the global competition in a therapy area. Assess present and future milestones of competing drug development programmes, identifying threats and opportunities for your specific target based on unique criteria.
Efficiently monitor competitors, market threats, and companies’ financial data for quicker deal sourcing and due diligence. Stay on top of market trends and drug developments to inform your strategy, product development, licensing deals, and investment decisions.
Set up alerts to provide timely insights on competitor portfolios and landscapes. Utilise market sizing models, Archived Forecasts, and the Event Analyzer to track changes in predictions over time.
Conduct detailed competitive assessments to identify product threats and market competitors, assess the commercial potential of competitors, and utilise the NPV module for insights on the value of products and portfolios at a company and indication level across all pipeline and marketed programs.
Know which opportunities and markets offer the highest growth potential. Focus your resources strategically.
Find and validate pharma opportunities with a robust assessment of market fit, risk, uptake and sales forecasts, and more.
Know which opportunities and markets offer the highest growth potential. Focus your resources strategically.
Build a better understanding of your growth drivers and product differentiators with a clear analysis of market dynamics, trends, unmet needs, and competitors.
Determine the true worth and potential of assets, score high-value opportunities, and make confident licensing or acquisition decisions.
Triangulate internal assumptions and power your allocation strategy with external benchmarking data across the R&D landscape.
“Understand the M&A landscape, identify potential candidates for in-licensing and to run critical market research… Having access to the platform really increases our efficiency, and provides us with high-quality insights that aid our decision-making. In my experience, only Evaluate Pharma provides the level of details on forecasting and patent expiration data, and the ability to create custom reports is very useful.”
Understand the context with data-driven insights.
Kelly Chamberlain may not have been at the company very long, but that didn’t stop me swooping in to find out a little more about her. Kelly has joined Norstella,...
If you missed our recent webinar, AI and ML in Pharma: Redefining the Forecasting Landscape, then I hope it’s because you were on a lovely vacation somewhere. Now that you’re...
There is no shortage of discussion about the opportunities presented by artificial intelligence and AI in the pharma industry. 50% of global healthcare companies plan to implement AI strategies by...
Evaluate’s annual World Preview report is a must-read for many in the pharma industry. Each year, we pull together some of our key pharma forecasts to build a picture of...
Can Forecasting Help Identify Market Opportunities for Pharmaceutical Companies? Forecasting serves to help pharmaceutical companies identify market opportunities, particularly when taking a sales-based approach and considering the wider competitive set....
Many pharmaceutical companies are harnessing digital solutions to elevate global forecasting. Digital tools, such as cloud-based, SaaS environments, are powering efficient, streamlined, and intelligent forecasting processes. But, for technological solutions...